ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of November

November 28, 2014

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

NIH Defines Misconduct

December 9, 1994

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

Interview with Claudia Henschke: Observational Study Of Spiral CT Should Change Medical Practice, She Says.

November 3, 2006